相关实验视频
Updated: Jul 24, 2025

20:38
Isolation and Transplantation of Hematopoietic Stem Cells HSCs
Published on: February 25, 2007
23.8K
[HLA-哈普洛同一性干细胞移植]
1Department of Hematology, Sapporo Hokuyu Hospital.
概括
移植后循环胺 (PTCy) 能够进行HLA-haploidentical干细胞移植,表现出与匹配移植相似的结果. 这种方法通过减少移植对宿主疾病来提高全源移植的安全性.
科学领域:
- 血液学 血液学 血液学
- 免疫学 免疫学 免疫学
- 移植医学 移植医学
背景情况:
- 使用移植后环胺 (PTCy-haplo) 的HLA-haplo相同干细胞移植在全球范围内激增.
- 在日本,PTCy-haplo在2020年超过了与HLA匹配的兄弟移植,日本注册数据显示了相似的结果.
研究的目的:
- 审查日本PTCy-haplo日益增长的使用和结果.
- 探索影响PTCy-haplo疗效和安全性的因素.
- 突出PTCy在改善异构移植安全方面的潜力.
主要方法:
- 分析日本注册数据以进行回顾性结果比较.
- 关于PTCy在各种调节方案和干细胞来源中的应用的文献综述.
- 提到正在日本进行的潜在的II期试验.
主要成果:
- PTCy-haplo证明了与HLA匹配的无关和带血移植相似的结果.
- 使用PTCy进行外周血液干细胞移植可能会提供更好的结果,尽管移植对宿主疾病风险增加.
- 诸如CD34+细胞剂量,供体年龄和HLA不匹配等因素影响PTCy-haplo结果.
结论:
- PTCy有效地减少了移植与宿主疾病的发生,提高了全源干细胞移植的安全性.
- 扩大PTCy-haplo的使用意味着向更安全,更容易获得的 haploidentical 移植转变.
- 预计即将发布的试验结果将进一步验证PTCy在优化移植方案中的作用.
更多相关视频
11:55Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade
Published on: March 14, 2011
14.6K
03:40Author Spotlight: Exploring the Lifespan Dynamics of Healthy Human Hematopoiesis
Published on: December 8, 2023
1.1K
相关概念视频
Multipotency of Hematopoietic Stem Cells
3.1K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.1K
Tissue Transplantation
415
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
415
Bone Marrow Sampling and Transplants
363
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
363
Stem Cell Therapy for Tissue Regeneration
4.1K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.1K
iPS Cell Differentiation
2.7K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K